Dergiler / Eurasian Journal of Medical Investigation / 2022 / Cilt: 6 - Sayı: 2

Long-Term Effects of COVID-19 Pandemic on Oncology Patients

Sayfa
198–202
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Although the regulations were detrimental to chemotherapy adherence, the overall mortality between groups did not differ.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: COVID-19 pandemic affects the health care systems in the whole world.
📊
Temel Bulgular & Veri:Results: Before March 11, 2020, 52 patients experienced four delayed chemotherapy treatments (3.7%), compared to 43 delayed chemotherapy treatments (39.8%9) in 107 patients (39.8%) after the first case of COVID-19 was recorded in Turkey and restrictions started to be applied.
💡
Sonuç & Katkı:Although the regulations were detrimental to chemotherapy adherence, the overall mortality between groups did not differ.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: COVID-19 pandemic affects the health care systems in the whole world. In this study, we try to evaluate the prognostic effect of the chemotherapy delay or cessation of the patients due to hospital fear and social regulations. Methods: Patients on active cancer treatment were retrospectively analyzed. The age, gender, diagnosis, chemotherapy type, rendezvous, and coming dates were recorded. Results: Before March 11, 2020, 52 patients experienced four delayed chemotherapy treatments (3.7%), compared to 43 delayed chemotherapy treatments (39.8%9) in 107 patients (39.8%) after the first case of COVID-19 was recorded in Turkey and restrictions started to be applied. No reason was given for the delayed treatments of 20 patients who did not show up for their chemotherapy appointments. The overall mortality of those who experienced treatment delays after the announcement of the COVID-19 pandemic was no different from those before. Conclusion: The non-specific regulations and declarations confused patients and prevented their access to their much-needed treatment. Although the regulations were detrimental to chemotherapy adherence, the overall mortality between groups did not differ.

🔖

Bu Makaleye Atıf Yap

BEYPINAR, I., ÜRÜN, M. (2022). Long-Term Effects of COVID-19 Pandemic on Oncology Patients. Eurasian Journal of Medical Investigation, Cilt: 6 - Sayı: 2, 198–202. https://ajindex.com/articles/508528

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13
  2. Xia Y, Jin R, Zhao J, et al. Risk of COVID-19 for patients with cancer. Lancet Oncol 21(4): e180, 2020
  3. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020;21:e181
  4. WHO. Weekly epidemiological update on COVID-19 - 18 January 2022. Available at: https://www.who.int/publications/m/ item/weekly-epidemiological-update-on-covid-19---18-january- 2022. Accessed Jan 19, 2022
  5. Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, et al. Practice recommendations for riskadapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys 2020;107:618–27
  6. Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, et al. Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. Neuro Oncol 2020;22:912–7
  7. T.C. İçişleri Bakanlığı. 30 Büyükşehir ve Zonguldak İlinde 23- 24-25-26 Nisan Tarihlerinde Uygulanacak Sokağa Çıkma Kısıtlaması. Available at: https://www.icisleri.gov.tr/30- buyuksehir-ve-zonguldak-ilinde-23-24-25-26-nisan-tarihlerinde- uygulanacak-sokaga-cikma-kisitlamasi. Accessed Mar 15, 2022
  8. Beypinar I, Urun M. Intravenous chemotherapy adherence of cancer patients in time of covid-19 crisis. Uluslararasi Hematoloji- Onkoloji Dergisi 2020;30:133–8
  9. Karacin C, Bilgetekin I, B Basal F, Oksuzoglu OB. How does COVID- 19 fear and anxiety affect chemotherapy adherence in patients with cancer. Future Oncol 2020;16:2283–93
  10. Guven DC, Aktas BY, Aksun MS, Ucgul E, Sahin TK, Yildirim HC, et al. COVID-19 pandemic: Changes in cancer admissions. BMJ Supportive & Palliative Care 2020;0:1–4
  11. Akagunduz B, Ozer M, Karacin C, Atcı MM, Yıldırım HC, Unver E. Impact of coronaphobia on treatment and follow-up compliance of cancer patients. Future Oncol 2021;17:2621–9 12. Greer JA, Pirl WF, Park ER, Lynch TJ, Temel JS. Beh avioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 2008;65:549–52
  12. Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, Mac- Donald JJ, et al. Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Canc Netw 2019;17:221–